Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Five-year experience with implantable defibrillators in children

R M Hamilton1, P Dorian, R M Gow

  • 1Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario.

The American Journal of Cardiology
|March 1, 1996
PubMed
Summary

Implantable cardioverter-defibrillators are safe and effective for children aged 4-16 at high risk of sudden cardiac death. No deaths occurred in the study group, with 6 of 11 patients receiving appropriate shocks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical value of anti-desmoglein-2 antibodies in arrhythmogenic right ventricular cardiomyopathy: real-world evidence.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Partnering with survivors & families to determine research priorities for adult out-of-hospital cardiac arrest: A James Lind Alliance Priority Setting Partnership.

Resuscitation plus·2021
Same author

Prolonged P wave duration is associated with right atrial dimensions, but not atrial arrhythmias, in middle-aged endurance athletes.

Journal of electrocardiology·2019
Same author

Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.

Clinical genetics·2015
Same author

A pedigree-based genetic appraisal of Boxer ARVC and the role of the Striatin mutation.

The Veterinary record·2015
Same author

The effects of long chain polyunsaturated fatty acids on local activation properties in dogs vulnerable to atrial fibrillation.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2015

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Sudden cardiac death (SCD) is a critical concern in pediatric populations.
  • Identifying children at high risk for SCD is essential for timely intervention.
  • Implantable cardioverter-defibrillators (ICDs) are established treatments for SCD prevention in adults.

Purpose of the Study:

  • To evaluate the safety and efficacy of implantable cardioverter-defibrillators (ICDs) in pediatric patients.
  • To assess ICD performance in children with a history of sudden cardiac arrest or high risk for SCD.

Main Methods:

  • A retrospective analysis of pediatric patients (aged 4-16 years) who received ICDs over a 5-year period.
  • Inclusion of both transvenous and epicardial ICD implantation techniques.

Related Experiment Videos

  • Monitoring for mortality, device-related complications, and clinically appropriate shocks.

    • Main Results:

    • No mortality was observed in the study cohort during the follow-up period.
    • Six out of eleven patients experienced clinically appropriate shocks, indicating device efficacy.
    • Both transvenous and epicardial ICDs demonstrated safety and effectiveness in this pediatric group.

    Conclusions:

    • Implantable cardioverter-defibrillators are a safe and effective therapeutic option for children at high risk of sudden cardiac death.
    • ICD implantation can be successfully performed in pediatric patients, regardless of the surgical approach (transvenous or epicardial).
    • Further research may explore long-term outcomes and specific indications for ICDs in diverse pediatric cardiac conditions.